Hydromorphone Hydrochloride Injection
Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 11/01/2017
- Package NDC
- 0409-4264-01
- Generic name
- Hydromorphone Hydrochloride Injection
- Contact info
- 844-646-4398
- Availability
- Limited Availability
- Related info
- Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
- Update date
- 09/22/2026
- Dosage form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)
- Company name
- Hospira, Inc., a Pfizer Company
- Shortage reason
- Other
- Status
- Current
- Therapeutic category
- Analgesia/Addiction
- Harmonized identifiers (openFDA)
- Application number
- NDA200403
- Brand name
- HYDROMORPHONE HYDROCHLORIDE
- Generic name
- HYDROMORPHONE HYDROCHLORIDE
- Manufacturer name
- Hospira, Inc.
- Product NDC
- 0409-4264, 0409-1283, 0409-1312, 0409-1805
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Substance name
- HYDROMORPHONE HYDROCHLORIDE
- RxCUI
- 897756, 897757, 1433251, 1724383, 1724644, 2675350
- SPL ID
- 766e302a-2d03-4d93-b237-2348b57ee517
- SPL set ID
- f9ca2ef5-46d8-475a-a26e-f7c8becd6db7
- Package NDC
- 0409-1283-17, 0409-1283-37, 0409-1312-16, 0409-1312-36, 0409-4264-11, 0409-4264-01, 0409-1805-10, 0409-1805-01
- UNII
- L960UP2KRW